Production (Stage)
Inhibikase Therapeutics, Inc.
IKT
$1.95
-$0.01-0.51%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 93.18M | 97.54M | 3.24M | 7.94M | 9.75M |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 907.00K | 801.50K | 255.90K | 331.50K | 826.10K |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 77.50K | 106.30K | 690.50K | 331.30K | 232.40K |
| Total Current Assets | 94.16M | 98.45M | 4.19M | 8.60M | 10.81M |
|
|
|||||
| Total Current Assets | 94.16M | 98.45M | 4.19M | 8.60M | 10.81M |
| Net Property, Plant & Equipment | 116.60K | 148.50K | 186.80K | 224.00K | 260.30K |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | 94.28M | 98.60M | 4.38M | 8.83M | 11.07M |
|
|
|||||
| Total Accounts Payable | 1.69M | 943.00K | 2.53M | 1.34M | 1.29M |
| Total Accrued Expenses | 3.51M | 2.68M | 2.16M | 2.03M | 2.51M |
| Short-term Debt | -- | -- | 71.70K | 177.30K | 280.60K |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 74.80K | 110.50K | 145.20K | 152.20K | 151.20K |
| Total Finance Division Other Current Liabilities | 3.27M | -- | -- | -- | -- |
| Total Other Current Liabilities | 3.27M | -- | -- | -- | -- |
| Total Current Liabilities | 8.55M | 3.73M | 4.91M | 3.70M | 4.23M |
|
|
|||||
| Total Current Liabilities | 8.55M | 3.73M | 4.91M | 3.70M | 4.23M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | 71.70K | 177.30K | 280.60K |
| Capital Leases | -- | -- | -- | 25.60K | 58.30K |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 8.55M | 3.73M | 4.91M | 3.73M | 4.29M |
|
|
|||||
| Common Stock & APIC | 193.83M | 189.32M | 81.76M | 81.61M | 78.33M |
| Retained Earnings | -108.10M | -94.42M | -82.29M | -76.51M | -71.55M |
| Treasury Stock & Other | -1.00K | -37.20K | 1.80K | -1.00K | -1.80K |
| Total Common Equity | 85.73M | 94.87M | -530.60K | 5.10M | 6.78M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 85.73M | 94.87M | -530.60K | 5.10M | 6.78M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 85.73M | 94.87M | -530.60K | 5.10M | 6.78M |
|
|
|||||